Meyka Pro banner
Henry Schein, Inc.

Henry Schein, Inc. (HSIC) Stock Overview

Explore Henry Schein, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HSIC●NASDAQ
HealthcareMedical - Distribution
$84.97
$1.02(1.19%)
U.S. Market opens in 6h 5m

Henry Schein, Inc. (HSIC)

Meyka AI Score

Z

Key Financials

Market Cap9.7B
P/E Ratio24.54
EPS (TTM)$5.31
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$81.78
3 Months$93.86
1 Year Target$86.03

HSIC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Henry Schein, Inc. (NASDAQ: HSIC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Henry Schein, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HSIC on the NASDAQ shows an RSI of 41.16, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $86.03 for the NASDAQ listing.

Key metrics behind Henry Schein, Inc.'s NASDAQ-traded stock include a P/E ratio of 24.54 and a market capitalization of 9.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HSIC on the NASDAQ.

Price Performance (NASDAQ: HSIC)

1-Day Change
-1.19%
5-Day Change
0.56%
1-Month Change
-5.08%
3-Month Change
0.81%
6-Month Change
17.85%
Year-to-Date (YTD) Change
12.42%
1-Year Change
28.64%
3-Year Change
14.44%
5-Year Change
8.55%
All-Time (Max) Change
1804.82%

Contact Information

631 843 5500
135 Duryea Road, Melville, NY, 11747

Company Facts

250,000 Employees
IPO DateNov 3, 1995
CountryUS
Actively Trading

Frequently Asked Questions